LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_000314.8_c.147del_20261117_162926
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.147del

PTEN  · NP_000305.3:p.(Asn49LysfsTer5)  · NM_000314.8
GRCh37: chr10:89653848 AT>A  ·  GRCh38: chr10:87894091 AT>A
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Asn49LysfsTer5)
gnomAD AF
ClinVar
Likely pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 (very strong): the c.147 frameshift is far 5' of p.Asp375 in the biologically relevant NM_000314.8 transcript and is predicted to undergo nonsense-mediated decay.
2
PM2 (supporting): NM_000314.8:c.147del is absent from gnomAD v2.1 and v4.1.
Final determination: Under Rule20 of the ClinGen PTEN Expert Panel Version 3.2 framework, one pathogenic very strong criterion plus one pathogenic supporting criterion yields a Likely Pathogenic classification.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met at very strong: c.147 frameshift is far 5' of PTEN p.D375 (c.1121) in the biologically relevant NM_000314.8 transcript.
cspec vcep_pvs1_decisiontree_pten pvs1_variant_assessment
PS1 N/A Not applicable: c.147del produces p.(Asn49LysfsTer5), a frameshift rather than a same-amino-acid missense change.
cspec
PS2 Not assessed Not assessed: no proband-level de novo observation, parental testing, maternity or paternity confirmation, or family-history information is available.
cspec
PS3 Not assessed Not assessed: mmc2 Table S2 contains no matching row for this frameshift, so the VCEP's ≤ -1.11 phosphatase threshold cannot be evaluated.
cspec vcep_mmc2 PMID:29706350
PS4 Not assessed Not assessed: no PTEN phenotype-specificity score or case-control counts, odds ratio, confidence interval, or p-value are available for c.147del.
cspec PMID:26467025
PM1 N/A Not applicable: residue 49 is outside all VCEP-defined catalytic motifs, which are limited to residues 90-94, 123-130, and 166-168.
cspec hotspots
PM2 Met Met at supporting strength: the variant was absent from gnomAD v2.1 and v4.1, satisfying the VCEP PM2 population-absence requirement below 0.00001 allele frequency.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN Expert Panel explicitly designates PM3 as not applicable to PTEN.
cspec
PM4 N/A Not applicable: PM4 covers in-frame indels or stop-loss variants, whereas c.147del is a frameshift.
cspec pvs1_variant_assessment
PM5 N/A Not applicable: PM5 requires a missense change, but c.147del produces the frameshift p.(Asn49LysfsTer5).
cspec
PM6 Not assessed Not assessed: no presumed de novo observation with disease and no family history is documented for this variant.
cspec
PP1 Not assessed Not assessed: no affected relatives, variant-status results, cosegregation observations, or meiosis count are documented.
cspec
PP2 N/A Not applicable: PP2 is limited to missense variants, whereas c.147del produces the frameshift p.(Asn49LysfsTer5).
cspec
PP3 N/A Not applicable: PTEN PP3 covers synonymous/intronic splice predictions or missense REVEL >0.7, whereas c.147del is a frameshift variant.
cspec
PP4 N/A Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 Use 2 and explicitly excludes independent PP4 application.
cspec
PP5 N/A Not applicable: the PTEN VCEP explicitly states that PP5 is not for use.
cspec
BA1 Not met Not met: the variant was absent from gnomAD v2.1 and v4.1, rather than exceeding the VCEP BA1 threshold of >0.00056 allele frequency.
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant was absent from gnomAD v2.1 and v4.1, with no allele frequency in either VCEP BS1 range of 0.0000043–0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: gnomAD reports no variant record but provides no homozygote observation or healthy-individual clinical status required by the VCEP BS2 rule.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: mmc2 Table S2 contains no matching row for this frameshift, so the VCEP's >0 phosphatase threshold cannot be evaluated.
cspec vcep_mmc2 PMID:29706350
BS4 Not assessed Not assessed: no affected relatives lacking the variant or family-level non-segregation observations are documented.
cspec
BP1 N/A Not applicable: the PTEN VCEP explicitly marks BP1 as Not Applicable.
cspec
BP2 Not assessed Not assessed: no qualifying trans observation or three cis/phase-unknown observations with different pathogenic PTEN variants are documented.
cspec
BP3 N/A Not applicable: the PTEN VCEP explicitly marks BP3 as not applicable in its Version 3.2 criteria.
cspec
BP4 N/A Not applicable: PTEN BP4 covers synonymous/intronic splice predictions or missense REVEL <0.5, while c.147del is a frameshift with a truncating protein effect.
cspec
BP5 Not assessed Not assessed: no two qualifying cases with an alternate highly penetrant disorder and non-overlapping PTEN history are documented.
cspec
BP6 N/A Not applicable: the PTEN VCEP explicitly states that BP6 is not for use.
cspec
BP7 N/A Not applicable: PTEN BP7 requires a synonymous or intronic variant at or beyond +7/-21, but c.147del is a coding frameshift variant.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.